<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.0 20120330//EN" "JATS-archivearticle1.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article" xml:lang="en"><?properties open_access?><front><journal-meta><journal-id journal-id-type="nlm-ta">Lipids Health Dis</journal-id><journal-id journal-id-type="iso-abbrev">Lipids Health Dis</journal-id><journal-title-group><journal-title>Lipids in Health and Disease</journal-title></journal-title-group><issn pub-type="epub">1476-511X</issn><publisher><publisher-name>BioMed Central</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmid">24673894</article-id><article-id pub-id-type="pmc">3986820</article-id><article-id pub-id-type="publisher-id">1476-511X-13-57</article-id><article-id pub-id-type="doi">10.1186/1476-511X-13-57</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research</subject></subj-group></article-categories><title-group><article-title>Short-term intake of a Japanese-style healthy lunch menu contributes to prevention and/or improvement in metabolic syndrome among middle-aged men: a non-randomized controlled trial</article-title></title-group><contrib-group><contrib contrib-type="author" id="A1"><name><surname>Inoue</surname><given-names>Hiroko</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>inoue@u-shizuoka-ken.ac.jp</email></contrib><contrib contrib-type="author" id="A2"><name><surname>Sasaki</surname><given-names>Ryosuke</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>rs_nosuke@hotmail.co.jp</email></contrib><contrib contrib-type="author" id="A3"><name><surname>Aiso</surname><given-names>Izumi</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>s12606@u-shizuoka-ken.ac.jp</email></contrib><contrib contrib-type="author" corresp="yes" id="A4"><name><surname>Kuwano</surname><given-names>Toshiko</given-names></name><xref ref-type="aff" rid="I1">1</xref><email>kuwano@u-shizuoka-ken.ac.jp</email></contrib></contrib-group><aff id="I1"><label>1</label>Department of Food and Nutritional Sciences and Environmental Health Sciences, Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, 52-1 Yada, Suruga-ku, Shizuoka 422-8526, Japan</aff><pub-date pub-type="collection"><year>2014</year></pub-date><pub-date pub-type="epub"><day>27</day><month>3</month><year>2014</year></pub-date><volume>13</volume><fpage>57</fpage><lpage>57</lpage><history><date date-type="received"><day>30</day><month>1</month><year>2014</year></date><date date-type="accepted"><day>6</day><month>3</month><year>2014</year></date></history><permissions><copyright-statement>Copyright &#x000a9; 2014 Inoue et al.; licensee BioMed Central Ltd.</copyright-statement><copyright-year>2014</copyright-year><copyright-holder>Inoue et al.; licensee BioMed Central Ltd.</copyright-holder><license license-type="open-access" xlink:href="http://creativecommons.org/licenses/by/2.0"><license-p>This is an Open Access article distributed under the terms of the Creative Commons Attribution License (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (
<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/publicdomain/zero/1.0/">http://creativecommons.org/publicdomain/zero/1.0/</ext-link>) applies to the data made available in this article, unless otherwise stated.</license-p></license></permissions><self-uri xlink:href="http://www.lipidworld.com/content/13/1/57"/><abstract><sec><title>Background</title><p>Metabolic syndrome is now widely appreciated as a cluster of metabolic abnormalities such as visceral obesity, hypertension, hyperglycemia and dyslipidemia. To date, incidence of metabolic syndrome is continuously increasing worldwide.</p><p>In addition, low vegetable consumption has recently become a serious issue in Japan. Furthermore, Japan is facing a shortfall in places offering food that can help prevent metabolic syndrome in the first place. Our study is designed to influence these developments. We conducted a non-randomized controlled trial by offering a Japanese-style healthy lunch menu to middle-aged men in a workplace cafeteria. This menu was designed to prevent and reduce metabolic syndrome.</p></sec><sec><title>Methods</title><p>This intervention study took the form of a non-randomized controlled trial. Participants chose the control or intervention group. The control group consumed their habitual lunches without restriction and only nutrient contents were assessed. The intervention group received a Japanese-style healthy lunch at a workplace cafeteria for 3&#x000a0;months. The participants worked in offices at a city hall and mostly had low levels of physical activity. Data of 35 males (control group: 7 males, intervention group: 28 males, mean age: 47.2&#x02009;&#x000b1;&#x02009;7.9&#x000a0;years) were collected and analyzed.</p></sec><sec><title>Results</title><p>We obtained an effective outcome by demonstrating that ongoing intake of a Japanese-style healthy lunch decreased blood pressure and serum lipids and increased plasma ghrelin levels. The results grew more pronounced as intake of Japanese-style healthy lunches increased in frequency.</p></sec><sec><title>Conclusions</title><p>This study presents new empirical data as a result of an original intervention program undertaken in Japan. A Japanese-style healthy lunch menu containing many vegetables consumed can help prevent and/or improve metabolic syndrome.</p></sec></abstract><kwd-group><kwd>Workplace cafeteria</kwd><kwd>Metabolic syndrome</kwd><kwd>Japanese-style healthy lunch menu</kwd><kwd>Blood pressure</kwd><kwd>Serum lipids</kwd></kwd-group></article-meta></front><body><sec><title>Background</title><p>Washoku (Japanese-style diet) was recognized as a cultural treasure by UNESCO in 2013. A Japanese-style diet features a grain dish (syusyoku in Japanese), side vegetable dishes (fukusai in Japanese), and a main meat or fish dish (syusai in Japanese), which offer balanced nutrition
[<xref ref-type="bibr" rid="B1">1</xref>]. The Japanese-style diet contains little animal fat and is a healthy diet.</p><p>On the other hand, metabolic syndrome, which is closely associated with abdominal obesity, type 2 diabetes, and cardiovascular disease (CVD), has become a global epidemic in developed nations, including Japan
[<xref ref-type="bibr" rid="B2">2</xref>,<xref ref-type="bibr" rid="B3">3</xref>]. Metabolic syndrome is a cluster of metabolic abnormalities characterized by concurrent hyperglycemia, hypertension, high triacylglycerol (TG) levels, low high-density lipoprotein cholesterol (HDL-Chol) levels, and inflammation
[<xref ref-type="bibr" rid="B4">4</xref>,<xref ref-type="bibr" rid="B5">5</xref>]. These major components are often associated with decreased insulin sensitivity, proinflammatory, pro-oxidant, and prothrombotic states, and low levels of cardiorespiratory fitness
[<xref ref-type="bibr" rid="B5">5</xref>]. The National Health Promotion Campaigns for the 21<sup>st</sup> Century (Healthy Japan 21), supported by the Japanese Ministry of Health, Labour and Welfare (2000) recommends that adults ingest&#x02009;&#x02265;&#x02009;350&#x000a0;g of vegetables per day
[<xref ref-type="bibr" rid="B6">6</xref>]. However, all age groups in Japan are falling short of this goal
[<xref ref-type="bibr" rid="B7">7</xref>]. Some intervention studies focusing on vegetable intake to prevent metabolic syndrome and improve abdominal obesity have been undertaken, but few have taken place in Japan
[<xref ref-type="bibr" rid="B8">8</xref>]. The Mediterranean diet has been studied in detail
[<xref ref-type="bibr" rid="B9">9</xref>-<xref ref-type="bibr" rid="B11">11</xref>], and some intervention studies have examined the effects of consuming low-carbohydrate and low-fat diets
[<xref ref-type="bibr" rid="B12">12</xref>]. Epidemiological surveys have applied principal component analysis to investigations into metabolic syndrome, CVD, and associations between food consumption patterns and metabolic syndrome
[<xref ref-type="bibr" rid="B13">13</xref>,<xref ref-type="bibr" rid="B14">14</xref>].</p><p>We conducted the first intervention study by providing a Japanese-style healthy lunch menu to middle-aged men at a workplace cafeteria in order to prevent and/or improve metabolic syndrome.</p></sec><sec sec-type="methods"><title>Methods</title><sec><title>Participants</title><p>The study participants work in an office in the S city hall and none partake in daily exercise. They only engage in desk work and commute by train or a bus. Given the office-bound nature of their jobs, even mild activity such as walking in the course of work is minimal.</p></sec><sec><title>Sample selection</title><p>After explaining the study aim and procedure to the entire office, we enrolled sufficient participants to begin. A recruitment period of the study participants was one month.</p><p>We chose not to consider taking medicine for fat or carbohydrate metabolism as exclusion criteria. We excluded data of participants (<italic>n</italic>&#x02009;=&#x02009;23) who left in the middle of the study. Data of 35 males (mean age, 47.2&#x02009;&#x000b1;&#x02009;7.9&#x000a0;years) were finally included in our analysis (Figure&#x000a0;
<xref ref-type="fig" rid="F1">1</xref>).</p><fig id="F1" position="float"><label>Figure 1</label><caption><p><bold>Flow diagram of study participants.</bold> Participants were non-randomized when assigned to the control or intervention group. We chose not to use medicine as criteria of participant recruitment. We chose not to consider taking medicine for fat or carbohydrate metabolism as exclusion criteria. We excluded data of participants who left in the middle of the study. Data of 35 males were finally analyzed.</p></caption><graphic xlink:href="1476-511X-13-57-1"/></fig></sec><sec><title>Ethics</title><p>The University of Shizuoka Review Board approved the study protocol, and all selected workers provided written informed consent for their participation (No. 20&#x02013;5).</p></sec><sec><title>Study design</title><p>This intervention study was a non-randomized controlled trial. Participants were able to self-select the control or intervention group. The intervention group received a Japanese-style healthy lunch at their workplace cafeteria for 3&#x000a0;months. The total intake number of a Japanese-style healthy lunch menu is 61 times. The control group consumed their habitual lunches without restriction and only nutrient contents were assessed. The weekend dietary habits of all the participants were also unrestricted.</p></sec><sec><title>Concept of a Japanese-style healthy lunch menu</title><p>The energy and nutrition contents of the provided Japanese-style healthy lunch menu were based on the Guidelines for the Diagnosis and Prevention of Atherosclerotic Cardiovascular Diseases (Japan Atherosclerosis Society, 2007)
[<xref ref-type="bibr" rid="B15">15</xref>]. The criteria for vegetable intake matched those recommended by Healthy Japan 21. We calculated the nutritive value of the healthy lunch using the standard body type described in the results of the 2006 National Health and Nutrition survey in Japan
[<xref ref-type="bibr" rid="B7">7</xref>]. We designed the Japanese-style healthy lunch menu to provide balanced nutrition and sufficient vegetable consumption over the course of three months (600&#x000a0;kcal&#x02009;&#x02264;&#x02009;Energy&#x02009;&#x0003c;&#x02009;650&#x000a0;kcal, Fat&#x02009;&#x0003c;&#x02009;18&#x000a0;g, Cholesterol&#x02009;&#x02264;&#x02009;100&#x000a0;mg, Fiber&#x02009;&#x02265;&#x02009;8&#x000a0;g, Total vegetables&#x02009;&#x02265;&#x02009;130&#x000a0;g, Sodium chloride equivalent&#x02009;&#x02264;&#x02009;3.8&#x000a0;g). The cook of the work cafeteria cooked the menu which we made a nutrient calculation.</p></sec><sec><title>Nutrition assessment</title><p>We assessed the participants before and after the study intervention (consumption of Japanese healthy-style lunches for 3&#x000a0;months) in terms of the following items: anthropometric data, blood parameters, and dietary intake. All participants fasted after 8:00&#x000a0;p.m. on the day before the anthropometric measurements and blood collection. Weight and BFP (%) were measured using a BODY FAT ANALYZER TBF-215 (Tanita Co. Ltd., Tokyo, Japan). Height and weight were measured while standing barefoot and wearing light clothing. Abdominal circumference was measured after exhalation at the position of the navel by the same staff member. Blood pressure was measured using a Medinote HEM-5001 digital automatic sphygmomanometer (Omron Health Care Co. Ltd., Kyoto, Japan).</p></sec><sec><title>Blood analysis</title><p>A nurse collected blood from fasting participants early in the morning. Blood was placed in vacuum tubes containing EDTA-2Na and trasylol for the active ghrelin and desacyl ghrelin analyses and into vacuum tubes containing heparin otherwise. Plasma was promptly collected by centrifugation at 1200 &#x000d7; <italic>g</italic> for 15&#x000a0;min at 4&#x000b0;C for active ghrelin and desacyl ghrelin analyses, placed in microtubes, mixed with hydrochloric acid (10%&#x000a0;v/v), and stored at -80&#x000b0;C. Plasma active ghrelin and desacyl ghrelin levels were measured using ELISA kits (Mitsubishi Kagaku Latron Inc., Tokyo, Japan). We measured serum levels for T-Chol, LDL-Chol, HDL-Chol, TG, glucose, HbA<sub>1C</sub> and leptin.</p><p>Serum was separated by centrifugation at 1200 &#x000d7; <italic>g</italic> and 4&#x000b0;C for 15&#x000a0;min after blood collection. Serum T-Chol, LDL-Chol, HDL-Chol, TG, glucose and HbA<sub>1C</sub> levels were measured at SRL Inc. (Tokyo, Shizuoka, Japan). Serum leptin levels were measured using Human Leptin Quantikine ELISA kits (R&#x00026;D Systems, Inc., Minneapolis, MN, USA).</p></sec><sec><title>Dietary intake</title><p>Dietary intake was assessed using a 24-h dietary recall at baseline and after 3&#x000a0;months. We collected data regarding daily total intake for the day before assessment. Participants were instructed to partake in a weekday normal diet without events such as the ceremonial occasion beforehand on the day of the diet survey. The diet was documented by RD for precision and consistency. The participants answered questions about typical daily food intake, frequency of eating during the day, and variety and brand of consumed foods. Nutrition and food intake was analyzed using EXCEL Eiyo-kun software version 5.0 (Kenpaku-sha Co. Ltd., Tokyo, Japan).</p></sec><sec><title>Statistical analysis</title><p>Data were analyzed using SPSS software (version 18.0, SPSS Inc., Chicago, IL, USA). Normalcy of the data was assessed using the Shapiro&#x02013;Wilk test. Statistical differences were assessed using either comparison between the control and intervention groups at baseline parameters analyzed by independent sample t-test (case of parametric data) or Mann&#x02013;Whitney test (case of non-parametric data). Statistical differences between the baseline parameters and the parameters after 3&#x000a0;months were analyzed by paired t-test (parametric data) or Wilcoxon&#x02019;s signed rank test (non-parametric data). The intervention group was divided into two groups for analysis (Japanese-style healthy lunch menu intake frequency of&#x02009;&#x0003c;&#x02009;50%ile and Japanese-style healthy lunch menu intake frequency of&#x02009;&#x02265;&#x02009;50%ile). The group with an intake frequency of &#x0003c;50%ile ate the Japanese-style healthy lunch menu less than 50 times out of the total 61 times. The group with an intake frequency of&#x02009;&#x02265;&#x02009;50%ile ate the Japanese-style healthy lunch menu more than 51 times out of the total 61 times.</p><p>The significance level was set at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05. All data are described as means&#x02009;&#x000b1;&#x02009;standard deviation.</p></sec></sec><sec sec-type="results"><title>Results</title><sec><title>Baseline characteristics of participants</title><p>Table&#x000a0;
<xref ref-type="table" rid="T1">1</xref> shows anthropometric, blood marker, and dietary intake data. Total- Cholesterol (T-Chol) levels were significantly higher in the intervention group than in the control group. On the other hand, significant differences in other blood markers or food intake were not observed between the two groups.</p><table-wrap position="float" id="T1"><label>Table 1</label><caption><p>Baseline characteristics of participants</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center" valign="bottom"><bold>Characteristics</bold><hr/></th><th align="center" valign="bottom"><bold>Control group</bold><hr/></th><th align="center" valign="bottom"><bold>Intervention group</bold><hr/></th><th rowspan="2" align="center"><bold>p value</bold></th><th align="center" valign="bottom"><bold>All</bold><hr/></th></tr><tr><th align="center">&#x000a0;</th><th align="center"><bold>(n&#x02009;=&#x02009;7)</bold></th><th align="center"><bold>(n&#x02009;=&#x02009;28)</bold></th><th align="center"><bold>(n&#x02009;=&#x02009;35)</bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">Age (y)*<hr/></td><td align="center" valign="bottom">42.1&#x02009;&#x000b1;&#x02009;4.5<hr/></td><td align="center" valign="bottom">48.5&#x02009;&#x000b1;&#x02009;8.1<hr/></td><td align="center" valign="bottom">0.013<hr/></td><td align="center" valign="bottom">47.2&#x02009;&#x000b1;&#x02009;7.9<hr/></td></tr><tr><td align="center" valign="bottom">Height (cm)*<hr/></td><td align="center" valign="bottom">174.3&#x02009;&#x000b1;&#x02009;4.4<hr/></td><td align="center" valign="bottom">168.0&#x02009;&#x000b1;&#x02009;5.8<hr/></td><td align="center" valign="bottom">0.012<hr/></td><td align="center" valign="bottom">169.3&#x02009;&#x000b1;&#x02009;6.0<hr/></td></tr><tr><td align="center" valign="bottom">Weight (kg)&#x02020;<hr/></td><td align="center" valign="bottom">70.4&#x02009;&#x000b1;&#x02009;13.1<hr/></td><td align="center" valign="bottom">71.8&#x02009;&#x000b1;&#x02009;11.3<hr/></td><td align="center" valign="bottom">0.773<hr/></td><td align="center" valign="bottom">71.5&#x02009;&#x000b1;&#x02009;11.5<hr/></td></tr><tr><td align="center" valign="bottom">BMI (kg/m<sup>2</sup>)*<hr/></td><td align="center" valign="bottom">23.1&#x02009;&#x000b1;&#x02009;3.9<hr/></td><td align="center" valign="bottom">25.4&#x02009;&#x000b1;&#x02009;3.3<hr/></td><td align="center" valign="bottom">0.130<hr/></td><td align="center" valign="bottom">24.9&#x02009;&#x000b1;&#x02009;3.5<hr/></td></tr><tr><td align="center" valign="bottom">BFP (%)&#x02020;<hr/></td><td align="center" valign="bottom">23.6&#x02009;&#x000b1;&#x02009;6.5<hr/></td><td align="center" valign="bottom">26.1&#x02009;&#x000b1;&#x02009;5.8<hr/></td><td align="center" valign="bottom">0.208<hr/></td><td align="center" valign="bottom">25.6&#x02009;&#x000b1;&#x02009;5.9<hr/></td></tr><tr><td align="center" valign="bottom">SBP (mmHg)&#x02020;<hr/></td><td align="center" valign="bottom">127.3&#x02009;&#x000b1;&#x02009;10.0<hr/></td><td align="center" valign="bottom">138.8&#x02009;&#x000b1;&#x02009;14.1<hr/></td><td align="center" valign="bottom">0.117<hr/></td><td align="center" valign="bottom">136.5&#x02009;&#x000b1;&#x02009;14.0<hr/></td></tr><tr><td align="center" valign="bottom">DBP (mmHg)*<hr/></td><td align="center" valign="bottom">81.3&#x02009;&#x000b1;&#x02009;7.4<hr/></td><td align="center" valign="bottom">89.3&#x02009;&#x000b1;&#x02009;11.0<hr/></td><td align="center" valign="bottom">0.080<hr/></td><td align="center" valign="bottom">87.7&#x02009;&#x000b1;&#x02009;10.8<hr/></td></tr><tr><td align="center" valign="bottom">Waist Circumference (cm)*<hr/></td><td align="center" valign="bottom">85.2&#x02009;&#x000b1;&#x02009;11.6<hr/></td><td align="center" valign="bottom">88.3&#x02009;&#x000b1;&#x02009;9.2<hr/></td><td align="center" valign="bottom">0.449<hr/></td><td align="center" valign="bottom">87.7&#x02009;&#x000b1;&#x02009;9.7<hr/></td></tr><tr><td align="center" valign="bottom">T-Chol (mg/dL)*<hr/></td><td align="center" valign="bottom">185&#x02009;&#x000b1;&#x02009;32<hr/></td><td align="center" valign="bottom">215&#x02009;&#x000b1;&#x02009;27<hr/></td><td align="center" valign="bottom">0.014<hr/></td><td align="center" valign="bottom">209&#x02009;&#x000b1;&#x02009;30<hr/></td></tr><tr><td align="center" valign="bottom">LDL-Chol (mg/dL)&#x02020;<hr/></td><td align="center" valign="bottom">105&#x02009;&#x000b1;&#x02009;44<hr/></td><td align="center" valign="bottom">131&#x02009;&#x000b1;&#x02009;31<hr/></td><td align="center" valign="bottom">0.194<hr/></td><td align="center" valign="bottom">126&#x02009;&#x000b1;&#x02009;35<hr/></td></tr><tr><td align="center" valign="bottom">HDL-Chol (mg/dL)*<hr/></td><td align="center" valign="bottom">49&#x02009;&#x000b1;&#x02009;17<hr/></td><td align="center" valign="bottom">56&#x02009;&#x000b1;&#x02009;10<hr/></td><td align="center" valign="bottom">0.157<hr/></td><td align="center" valign="bottom">55&#x02009;&#x000b1;&#x02009;12<hr/></td></tr><tr><td align="center" valign="bottom">Triacylglycerol (mg/dL)&#x02020;<hr/></td><td align="center" valign="bottom">240&#x02009;&#x000b1;&#x02009;374<hr/></td><td align="center" valign="bottom">158&#x02009;&#x000b1;&#x02009;95<hr/></td><td align="center" valign="bottom">0.343<hr/></td><td align="center" valign="bottom">175&#x02009;&#x000b1;&#x02009;182<hr/></td></tr><tr><td align="center" valign="bottom">Glucose (mg/dL)&#x02020;<hr/></td><td align="center" valign="bottom">114&#x02009;&#x000b1;&#x02009;18<hr/></td><td align="center" valign="bottom">114&#x02009;&#x000b1;&#x02009;24<hr/></td><td align="center" valign="bottom">0.805<hr/></td><td align="center" valign="bottom">114&#x02009;&#x000b1;&#x02009;23<hr/></td></tr><tr><td align="center" valign="bottom">Hemoglobin A1C (%)&#x02020;<hr/></td><td align="center" valign="bottom">5.0&#x02009;&#x000b1;&#x02009;0.3<hr/></td><td align="center" valign="bottom">5.4&#x02009;&#x000b1;&#x02009;0.7<hr/></td><td align="center" valign="bottom">0.120<hr/></td><td align="center" valign="bottom">5.3&#x02009;&#x000b1;&#x02009;0.6<hr/></td></tr><tr><td align="center" valign="bottom">Active ghrelin (fmol/mL)&#x02020;<hr/></td><td align="center" valign="bottom">3.5&#x02009;&#x000b1;&#x02009;5.7<hr/></td><td align="center" valign="bottom">1.7&#x02009;&#x000b1;&#x02009;4.6<hr/></td><td align="center" valign="bottom">0.614<hr/></td><td align="center" valign="bottom">2.0&#x02009;&#x000b1;&#x02009;4.8<hr/></td></tr><tr><td align="center" valign="bottom">Desacyl ghrelin (fmol/mL)&#x02020;<hr/></td><td align="center" valign="bottom">133.2&#x02009;&#x000b1;&#x02009;161.2<hr/></td><td align="center" valign="bottom">62.0&#x02009;&#x000b1;&#x02009;107.2<hr/></td><td align="center" valign="bottom">0.331<hr/></td><td align="center" valign="bottom">76.3&#x02009;&#x000b1;&#x02009;120.6<hr/></td></tr><tr><td align="center" valign="bottom">Leptin (pg/mL)&#x02020;<hr/></td><td align="center" valign="bottom">1692&#x02009;&#x000b1;&#x02009;1903<hr/></td><td align="center" valign="bottom">2574&#x02009;&#x000b1;&#x02009;2134<hr/></td><td align="center" valign="bottom">0.201<hr/></td><td align="center" valign="bottom">2398&#x02009;&#x000b1;&#x02009;2093<hr/></td></tr><tr><td align="center" valign="bottom">Energy (kcal)*<hr/></td><td align="center" valign="bottom">2206&#x02009;&#x000b1;&#x02009;473<hr/></td><td align="center" valign="bottom">2188&#x02009;&#x000b1;&#x02009;556<hr/></td><td align="center" valign="bottom">0.937<hr/></td><td align="center" valign="bottom">2191&#x02009;&#x000b1;&#x02009;534<hr/></td></tr><tr><td align="center" valign="bottom">Protein (g)*<hr/></td><td align="center" valign="bottom">75.6&#x02009;&#x000b1;&#x02009;14.9<hr/></td><td align="center" valign="bottom">76.8&#x02009;&#x000b1;&#x02009;23.0<hr/></td><td align="center" valign="bottom">0.892<hr/></td><td align="center" valign="bottom">76.6&#x02009;&#x000b1;&#x02009;21.4<hr/></td></tr><tr><td align="center" valign="bottom">Fat (g)*<hr/></td><td align="center" valign="bottom">64.7&#x02009;&#x000b1;&#x02009;15.0<hr/></td><td align="center" valign="bottom">67.1&#x02009;&#x000b1;&#x02009;23.5<hr/></td><td align="center" valign="bottom">0.792<hr/></td><td align="center" valign="bottom">66.6&#x02009;&#x000b1;&#x02009;21.9<hr/></td></tr><tr><td align="center" valign="bottom">Carbohydrate (g)*<hr/></td><td align="center" valign="bottom">310.2&#x02009;&#x000b1;&#x02009;122.8<hr/></td><td align="center" valign="bottom">308.6&#x02009;&#x000b1;&#x02009;93.1<hr/></td><td align="center" valign="bottom">0.969<hr/></td><td align="center" valign="bottom">308.9&#x02009;&#x000b1;&#x02009;97.7<hr/></td></tr><tr><td align="center" valign="bottom">Salt (g)*<hr/></td><td align="center" valign="bottom">11.3&#x02009;&#x000b1;&#x02009;3.3<hr/></td><td align="center" valign="bottom">12.0&#x02009;&#x000b1;&#x02009;3.8<hr/></td><td align="center" valign="bottom">0.648<hr/></td><td align="center" valign="bottom">11.9&#x02009;&#x000b1;&#x02009;3.7<hr/></td></tr><tr><td align="center" valign="bottom">Soluble dietary fiber (g)&#x02020;<hr/></td><td align="center" valign="bottom">3.0&#x02009;&#x000b1;&#x02009;0.7<hr/></td><td align="center" valign="bottom">3.4&#x02009;&#x000b1;&#x02009;1.6<hr/></td><td align="center" valign="bottom">0.680<hr/></td><td align="center" valign="bottom">3.4&#x02009;&#x000b1;&#x02009;1.5<hr/></td></tr><tr><td align="center" valign="bottom">Insoluble dietary fiber (g)*<hr/></td><td align="center" valign="bottom">12.0&#x02009;&#x000b1;&#x02009;3.0<hr/></td><td align="center" valign="bottom">11.1&#x02009;&#x000b1;&#x02009;4.0<hr/></td><td align="center" valign="bottom">0.599<hr/></td><td align="center" valign="bottom">11.3&#x02009;&#x000b1;&#x02009;3.8<hr/></td></tr><tr><td align="center" valign="bottom">Total dietary fiber (g)*<hr/></td><td align="center" valign="bottom">16.7&#x02009;&#x000b1;&#x02009;6.4<hr/></td><td align="center" valign="bottom">15.9&#x02009;&#x000b1;&#x02009;7.0<hr/></td><td align="center" valign="bottom">0.256<hr/></td><td align="center" valign="bottom">16.0&#x02009;&#x000b1;&#x02009;6.8<hr/></td></tr><tr><td align="center" valign="bottom">Green and yellow vegetable (g)&#x02020;<hr/></td><td align="center" valign="bottom">115.0&#x02009;&#x000b1;&#x02009;102.0<hr/></td><td align="center" valign="bottom">92.0&#x02009;&#x000b1;&#x02009;74.0<hr/></td><td align="center" valign="bottom">0.726<hr/></td><td align="center" valign="bottom">96.6&#x02009;&#x000b1;&#x02009;79.2<hr/></td></tr><tr><td align="center" valign="bottom">Other vegetable (g)*<hr/></td><td align="center" valign="bottom">240.1&#x02009;&#x000b1;&#x02009;128.5<hr/></td><td align="center" valign="bottom">182.1&#x02009;&#x000b1;&#x02009;119.8<hr/></td><td align="center" valign="bottom">0.267<hr/></td><td align="center" valign="bottom">193.7&#x02009;&#x000b1;&#x02009;121.9<hr/></td></tr><tr><td align="center">Total vegetable (g)*</td><td align="center">355.1&#x02009;&#x000b1;&#x02009;156.1</td><td align="center">274.1&#x02009;&#x000b1;&#x02009;168.1</td><td align="center">0.256</td><td align="center">290.3&#x02009;&#x000b1;&#x02009;166.8</td></tr></tbody></table><table-wrap-foot><p>Data shows mean&#x02009;&#x000b1;&#x02009;S.D.</p><p><italic>Abbreviations</italic>: <italic>BMI</italic> Body mass index, <italic>BFP</italic> Body fat percentage, <italic>SBP</italic> Systolic blood pressure, <italic>DBP</italic> diastolic blood pressure, <italic>T-Chol</italic> Total cholesterol, <italic>LDL-Chol</italic> Low-density lipoprotein cholesterol, <italic>HDL-Chol</italic> high-density lipoprotein cholesterol.</p><p><italic>*p</italic> stands for the difference between the control and intervention groups at baseline parameters analyzed by the independent sample t test. &#x02020;<italic>p</italic> stands for the difference between the control and intervention groups at baseline parameters analyzed by the Mann&#x02013;Whitney test.</p><p>Difference was considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></table-wrap-foot></table-wrap><p>The frequency of metabolic syndrome and an abdominal circumference of&#x02009;&#x02265;&#x02009;85&#x000a0;cm were 36.8% and 55.3%, respectively. Participants having an abdominal circumference of &#x02265;85&#x000a0;cm weighed more, had a higher body mass index (BMI), and lower serum HDL-Chol levels than the 40- to 49-year-old men described in the National Health and Nutrition survey of 2009
[<xref ref-type="bibr" rid="B7">7</xref>]. They also had higher serum hemoglobin A<sub>1C</sub> (HbA<sub>1C</sub>), glucose, T-Chol, and TG levels as well as higher fat intake. Overall, at baseline, the study participants had extremely low intake of vegetables.</p></sec><sec><title>Change in anthropometric data</title><p>Table&#x000a0;
<xref ref-type="table" rid="T2">2</xref> shows changes in anthropometric data for each group. The control group did not show significant differences in all anthropometric data between baseline and after 3&#x000a0;months compared with the intervention group. However, the control group displayed a tendency of increased systolic blood pressure (SBP) (127.3 versus 132.4&#x000a0;mmHg, <italic>p&#x02009;=</italic>&#x02009;0.063).</p><table-wrap position="float" id="T2"><label>Table 2</label><caption><p>Changes in anthropometric data</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th colspan="5" align="center" valign="bottom"><bold>Intervention group</bold><hr/></th></tr><tr><th align="center"><bold>Characteristics</bold></th><th align="center">&#x000a0;</th><th align="center"><bold>Control group</bold></th><th align="center"><bold>
<italic>p </italic>
</bold><bold>value</bold></th><th align="center"><bold>Intake frequency of &#x0003c;50% ile (</bold><bold>
<italic>n</italic>
</bold>&#x02009;<bold>=&#x02009;12)</bold></th><th align="center"><bold>
<italic>p </italic>
</bold><bold>value</bold></th><th align="center"><bold>Intake frequency of &#x02265;50% ile (</bold><bold>
<italic>n</italic>
</bold>&#x02009;<bold>=&#x02009;16)</bold></th><th align="center"><bold>
<italic>p </italic>
</bold><bold>value</bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">70.4&#x02009;&#x000b1;&#x02009;13.1<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">77.2&#x02009;&#x000b1;&#x02009;13.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">67.8&#x02009;&#x000b1;&#x02009;7.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Weight (kg)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.132*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.546*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.330&#x02020;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">71.5&#x02009;&#x000b1;&#x02009;12.8<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">77.5&#x02009;&#x000b1;&#x02009;13.5<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">67.4&#x02009;&#x000b1;&#x02009;6.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">23.1&#x02009;&#x000b1;&#x02009;3.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">27.2&#x02009;&#x000b1;&#x02009;3.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">24.0&#x02009;&#x000b1;&#x02009;2.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">BMI (kg/m<sup>2</sup>)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.175*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.618*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.210*<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">23.4&#x02009;&#x000b1;&#x02009;3.8<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">27.3&#x02009;&#x000b1;&#x02009;3.2<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">23.8&#x02009;&#x000b1;&#x02009;2.5<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">23.6&#x02009;&#x000b1;&#x02009;6.5<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">29.1&#x02009;&#x000b1;&#x02009;6.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">23.8&#x02009;&#x000b1;&#x02009;3.5<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">BFP (%)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.126*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.783&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.019*<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">24.1&#x02009;&#x000b1;&#x02009;6.8<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">29.0&#x02009;&#x000b1;&#x02009;7.2<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">22.7&#x02009;&#x000b1;&#x02009;3.6<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">127.3&#x02009;&#x000b1;&#x02009;10.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">140.5&#x02009;&#x000b1;&#x02009;13.1<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">137.5&#x02009;&#x000b1;&#x02009;15.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">SBP (mmHg)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.063*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.277*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.023&#x02020;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">132.4&#x02009;&#x000b1;&#x02009;10.8<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">138.1&#x02009;&#x000b1;&#x02009;14.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">131.9&#x02009;&#x000b1;&#x02009;16.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">81.3&#x02009;&#x000b1;&#x02009;7.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">90.5&#x02009;&#x000b1;&#x02009;11.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">88.4&#x02009;&#x000b1;&#x02009;10.6<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">DBP (mmHg)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.506*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.000*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.001*<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">80.3&#x02009;&#x000b1;&#x02009;7.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">86.3&#x02009;&#x000b1;&#x02009;11.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">80.8&#x02009;&#x000b1;&#x02009;8.7<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">85.2&#x02009;&#x000b1;&#x02009;11.6<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">91.8&#x02009;&#x000b1;&#x02009;10.8<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">85.7&#x02009;&#x000b1;&#x02009;7.1<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">WC (cm)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.861*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.307*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.129*<hr/></td></tr><tr><td align="center">&#x000a0;</td><td align="center">After 3&#x000a0;months</td><td align="center">85.0&#x02009;&#x000b1;&#x02009;13.2</td><td align="center">&#x000a0;</td><td align="center">91.0&#x02009;&#x000b1;&#x02009;10.9</td><td align="center">&#x000a0;</td><td align="center">84.8&#x02009;&#x000b1;&#x02009;7.4</td><td align="center">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p>Data shows mean&#x02009;&#x000b1;&#x02009;S.D.</p><p><italic>Abbreviations</italic>: <italic>BMI</italic> Body mass index, <italic>BFP</italic> Body fat percentage, <italic>SBP</italic> Systolic blood pressure, <italic>DBP</italic> Diastolic blood pressure, <italic>WC</italic> Waist circumference.</p><p>*<italic>p</italic> stands for the difference between the baseline parameters and the parameters after 3&#x000a0;months analyzed by the paired t-test.</p><p>&#x02020;<italic>p</italic> stands for the difference between the baseline parameters and the parameters after 3&#x000a0;months analyzed by Wilcoxon&#x02019;s signed rank test.</p><p>Difference was considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></table-wrap-foot></table-wrap><p>For our analysis, we instituted an eating rate cutoff value at the 50%ile. Diastolic blood pressure (DBP) significantly decreased after 3&#x000a0;months compared with the baseline in the Japanese-style healthy lunch menu intake frequency&#x02009;&#x0003c;&#x02009;50%ile group, (90.5&#x02009;&#x000b1;&#x02009;11.9 versus 86.3&#x02009;&#x000b1;&#x02009;11.4, <italic>p</italic>&#x02009;=&#x02009;0.000). In addition, body fat percentage (BFP), SBP, and DBP significantly decreased after 3&#x000a0;months compared with the baseline in the Japanese-style healthy lunch menu intake frequency&#x02009;&#x02265;&#x02009;50%ile group (BFP: 23.8&#x02009;&#x000b1;&#x02009;3.5 versus 22.7&#x02009;&#x000b1;&#x02009;3.6, <italic>p</italic>&#x02009;=&#x02009;0.019; SBP: 137.5&#x02009;&#x000b1;&#x02009;15.0 versus 131.9&#x02009;&#x000b1;&#x02009;16.9, <italic>p</italic>&#x02009;=&#x02009;0.023; DBP: 88.4&#x02009;&#x000b1;&#x02009;10.6 versus 80.8&#x02009;&#x000b1;&#x02009;8.7, <italic>p</italic>&#x02009;=&#x02009;0.001). BFP and blood pressure decreased in the participants consuming the Japanese-style healthy lunch at a high frequency.</p></sec><sec><title>Blood parameters</title><p>Table&#x000a0;
<xref ref-type="table" rid="T3">3</xref> shows changes in blood parameters for each group. HbA<sub>1C</sub> levels in the control group had significantly increased after 3&#x000a0;months compared with the baseline (4.99%&#x02009;&#x000b1;&#x02009;0.29% versus 5.13%&#x02009;&#x000b1;&#x02009;0.21%, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05). In contrast, serum T-Chol, low-density lipoprotein (LDL-Chol), levels in the Japanese-style healthy lunch menu intake frequency&#x02009;&#x02265;&#x02009;50%ile group significantly decreased (T-Chol: 211&#x02009;&#x000b1;&#x02009;27&#x000a0;mg/dL versus 199&#x02009;&#x000b1;&#x02009;22&#x000a0;mg/dL, <italic>p</italic>&#x02009;=&#x02009;0.006; LDL-Chol: 127&#x02009;&#x000b1;&#x02009;31&#x000a0;mg/dL versus 116&#x02009;&#x000b1;&#x02009;25&#x000a0;mg/dL, <italic>p&#x02009;=</italic>&#x02009;0.010). Furthermore, plasma active ghrelin and desacyl ghrelin levels significantly increased after 3&#x000a0;months compared with the baseline (active ghrelin: 1.9&#x02009;&#x000b1;&#x02009;5.9 fmol/mL versus 5.3&#x02009;&#x000b1;&#x02009;8.4 fmol/mL, <italic>p&#x02009;=</italic>&#x02009;0.001; desacyl ghrelin: 77.4&#x02009;&#x000b1;&#x02009;135.4 fmol/mL versus 115.7&#x02009;&#x000b1;&#x02009;180.7 fmol/mL). In the Japanese-style healthy lunch menu intake frequency&#x02009;&#x0003c;&#x02009;50%ile group, plasma active ghrelin and desacyl ghrelin levels significantly increased after 3&#x000a0;months compared with the baseline (active ghrelin: 1.4&#x02009;&#x000b1;&#x02009;2.0 fmol/mL versus 3.8&#x02009;&#x000b1;&#x02009;3.9 fmol/mL, <italic>p&#x02009;=</italic>&#x02009;0.008; desacyl ghrelin: 41.6&#x02009;&#x000b1;&#x02009;49.0 fmol/mL versus 101.4&#x02009;&#x000b1;&#x02009;89.3 fmol/mL). Leptin levels after 3&#x000a0;months significantly decreased compared with the baseline in both intervention groups. Serum lipid levels decreased and eating-related hormone levels improved in the participants consuming the Japanese-style healthy lunch at a high frequency.</p><table-wrap position="float" id="T3"><label>Table 3</label><caption><p>Change in blood parameters</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th colspan="5" align="center" valign="bottom"><bold>Intervention group</bold><hr/></th></tr><tr><th align="center"><bold>Characteristics</bold></th><th align="center">&#x000a0;</th><th align="center"><bold>Control group (</bold><bold>
<italic>n</italic>
</bold>&#x02009;<bold>=&#x02009;7)</bold></th><th align="center"><bold>
<italic>p </italic>
</bold><bold>value</bold></th><th align="center"><bold>Intake frequency of &#x0003c;50% ile (</bold><bold>
<italic>n</italic>
</bold>&#x02009;<bold>=&#x02009;12)</bold></th><th align="center"><bold>
<italic>p </italic>
</bold><bold>value</bold></th><th align="center"><bold>Intake frequency of &#x02265;50% ile (</bold><bold>
<italic>n</italic>
</bold>&#x02009;<bold>=&#x02009;16)</bold></th><th align="center"><bold>
<italic>p </italic>
</bold><bold>value</bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">185&#x02009;&#x000b1;&#x02009;32<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">222&#x02009;&#x000b1;&#x02009;26<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">211&#x02009;&#x000b1;&#x02009;27<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">T-Chol (mg/dL)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.191*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.229*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.006*<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">199&#x02009;&#x000b1;&#x02009;40<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">215&#x02009;&#x000b1;&#x02009;28<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">199&#x02009;&#x000b1;&#x02009;22<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">105&#x02009;&#x000b1;&#x02009;44<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">136&#x02009;&#x000b1;&#x02009;30<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">127&#x02009;&#x000b1;&#x02009;31<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">LDL-Chol (mg/dL)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.292*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.437*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.010*<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">109&#x02009;&#x000b1;&#x02009;45<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">132&#x02009;&#x000b1;&#x02009;26<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">116&#x02009;&#x000b1;&#x02009;25<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">49&#x02009;&#x000b1;&#x02009;17<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">53&#x02009;&#x000b1;&#x02009;7<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">59&#x02009;&#x000b1;&#x02009;11<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">HDL-Chol (mg/dL)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.522*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.287*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.073*<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">49&#x02009;&#x000b1;&#x02009;16<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">51&#x02009;&#x000b1;&#x02009;8<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">56&#x02009;&#x000b1;&#x02009;15<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">240&#x02009;&#x000b1;&#x02009;374<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">208&#x02009;&#x000b1;&#x02009;116<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">121&#x02009;&#x000b1;&#x02009;55<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Triacylglycerol (mg/dL)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.173&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.136&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.408&#x02020;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">289&#x02009;&#x000b1;&#x02009;436<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">181&#x02009;&#x000b1;&#x02009;67<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">115&#x02009;&#x000b1;&#x02009;51<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">113&#x02009;&#x000b1;&#x02009;18<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">108&#x02009;&#x000b1;&#x02009;19<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">118&#x02009;&#x000b1;&#x02009;28<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Glucose (mg/dL)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.735&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.583&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.255&#x02020;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">112&#x02009;&#x000b1;&#x02009;21<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">107&#x02009;&#x000b1;&#x02009;16<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">111&#x02009;&#x000b1;&#x02009;18<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">5.0&#x02009;&#x000b1;&#x02009;0.3<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">5.3&#x02009;&#x000b1;&#x02009;0.5<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">5.5&#x02009;&#x000b1;&#x02009;0.8<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Hemoglobin A1C (%)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.041&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.033&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.529&#x02020;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">5.1&#x02009;&#x000b1;&#x02009;0.2<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">5.4&#x02009;&#x000b1;&#x02009;0.5<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">5.5&#x02009;&#x000b1;&#x02009;0.7<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">3.5&#x02009;&#x000b1;&#x02009;5.7<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">1.4&#x02009;&#x000b1;&#x02009;2.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">1.9&#x02009;&#x000b1;&#x02009;5.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Active ghrelin (fmol/mL)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.128&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.008&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">.001&#x02020;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">6.4&#x02009;&#x000b1;&#x02009;7.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">3.8&#x02009;&#x000b1;&#x02009;3.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">5.3&#x02009;&#x000b1;&#x02009;8.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">133.2&#x02009;&#x000b1;&#x02009;161.2<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">41.6&#x02009;&#x000b1;&#x02009;49.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">77.4&#x02009;&#x000b1;&#x02009;135.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Desacyl ghrelin (fmol/mL)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">1.000&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.002&#x02020;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.001&#x02020;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">108.0&#x02009;&#x000b1;&#x02009;67.7<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">101.4&#x02009;&#x000b1;&#x02009;89.3<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">115.7&#x02009;&#x000b1;&#x02009;180.7<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">1692&#x02009;&#x000b1;&#x02009;1903<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">3611&#x02009;&#x000b1;&#x02009;2786<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">1797&#x02009;&#x000b1;&#x02009;999<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Leptin (pg/mL)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.074*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.001*<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.000&#x02020;<hr/></td></tr><tr><td align="center">&#x000a0;</td><td align="center">After 3&#x000a0;months</td><td align="center">308&#x02009;&#x000b1;&#x02009;219</td><td align="center">&#x000a0;</td><td align="center">610&#x02009;&#x000b1;&#x02009;391</td><td align="center">&#x000a0;</td><td align="center">313&#x02009;&#x000b1;&#x02009;158</td><td align="center">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p>Data shows mean&#x02009;&#x000b1;&#x02009;S.D. <italic>Abbreviations</italic>: <italic>T-Chol</italic> Total cholesterol, <italic>LDL-Chol</italic> Low-density lipoprotein cholesterol, <italic>HDL-Chol</italic> high-density lipoprotein cholesterol. *<italic>p</italic> stands for the difference between the baseline parameters and the parameters after 3&#x000a0;months analyzed by the paired t-test. &#x02020;<italic>p</italic> stands for the difference between the baseline parameters and the parameters after 3&#x000a0;months analyzed by Wilcoxon&#x02019;s signed rank test. Difference was considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></table-wrap-foot></table-wrap></sec><sec><title>Changes in nutrition intake determined by 24-h dietary recall</title><p>Table&#x000a0;
<xref ref-type="table" rid="T4">4</xref> show changes in nutrition intake for each group determined by 24-h dietary recall. The "other vegetable" intake in the control group showed a significant decrease after 3&#x000a0;months compared with the baseline (240.1&#x000a0;g&#x02009;&#x000b1;&#x02009;128.5&#x000a0;g versus 96.4&#x000a0;g&#x02009;&#x000b1;&#x02009;64.7&#x000a0;g, <italic>p</italic>&#x02009;=&#x02009;0.015). On the other hand, energy and carbohydrate intake significantly decreased after 3&#x000a0;months compared with the baseline in the Japanese-style healthy lunch menu intake frequency&#x02009;&#x0003c;&#x02009;50%ile group (energy: 2554&#x02009;&#x000b1;&#x02009;392&#x000a0;kcal versus 2104&#x02009;&#x000b1;&#x02009;393&#x000a0;kcal, <italic>p&#x02009;=</italic>&#x02009;0.042; carbohydrate: 359.6&#x02009;&#x000b1;&#x02009;85.2&#x000a0;g versus 295.8&#x02009;&#x000b1;&#x02009;45.3&#x000a0;g). Furthermore, total dietary fiber and total vegetables in the Japanese-style healthy lunch menu intake frequency&#x02009;&#x02265;&#x02009;50%ile group significantly increased (total dietary fiber: 15.3&#x02009;&#x000b1;&#x02009;5.2&#x000a0;g versus 30.4&#x02009;&#x000b1;&#x02009;20.9&#x000a0;g, <italic>p</italic>&#x02009;=&#x02009;0.047; total vegetables: 292.4&#x02009;&#x000b1;&#x02009;146.6&#x000a0;g versus 411.1&#x02009;&#x000b1;&#x02009;155.9&#x000a0;g, <italic>p&#x02009;=</italic>&#x02009;0.035). Vegetable intake increased in the intervention group with the use of the Japanese-style healthy lunch menu.</p><table-wrap position="float" id="T4"><label>Table 4</label><caption><p>Changes in dietary intake</p></caption><table frame="hsides" rules="groups" border="1"><colgroup><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/><col align="center"/></colgroup><thead valign="top"><tr><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th><th colspan="3" align="center" valign="bottom"><bold>Intervention group</bold><hr/></th><th align="center" valign="bottom">&#x000a0;<hr/></th></tr><tr><th align="center"><bold>Characteristics</bold></th><th align="center">&#x000a0;</th><th align="center"><bold>Control group (</bold><bold>
<italic>n</italic>
</bold>&#x02009;<bold>=&#x02009;7)</bold></th><th align="center"><bold>
<italic>p </italic>
</bold><bold>value</bold></th><th align="center"><bold>Intake frequency of &#x0003c;50% ile (</bold><bold>
<italic>n</italic>
</bold>&#x02009;<bold>=&#x02009;12)</bold></th><th align="center"><bold>
<italic>p </italic>
</bold><bold>value</bold></th><th align="center"><bold>Intake frequency of &#x02265;50% ile (</bold><bold>
<italic>n</italic>
</bold>&#x02009;<bold>=&#x02009;16)</bold></th><th align="center"><bold>
<italic>p </italic>
</bold><bold>value</bold></th></tr></thead><tbody valign="top"><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">2206&#x02009;&#x000b1;&#x02009;473<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">2554&#x02009;&#x000b1;&#x02009;392<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">1938&#x02009;&#x000b1;&#x02009;517<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Energy (kcal)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.336<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.042<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.543<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">2423&#x02009;&#x000b1;&#x02009;548<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">2104&#x02009;&#x000b1;&#x02009;393<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">2040&#x02009;&#x000b1;&#x02009;403<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">75.6&#x02009;&#x000b1;&#x02009;14.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">86.4&#x02009;&#x000b1;&#x02009;23.1<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">68.2&#x02009;&#x000b1;&#x02009;21.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Protein (g)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.266<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.765<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.028<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">84.4&#x02009;&#x000b1;&#x02009;13.6<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">82.9&#x02009;&#x000b1;&#x02009;25.6<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">90.9&#x02009;&#x000b1;&#x02009;30.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">64.7&#x02009;&#x000b1;&#x02009;15.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">78.8&#x02009;&#x000b1;&#x02009;19.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">55.7&#x02009;&#x000b1;&#x02009;15.5<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Fat (g)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.774<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.151<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.286<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">68.3&#x02009;&#x000b1;&#x02009;31.2<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">59.5&#x02009;&#x000b1;&#x02009;24.7<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">49.1&#x02009;&#x000b1;&#x02009;13.1<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">310.2&#x02009;&#x000b1;&#x02009;122.8<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">359.6&#x02009;&#x000b1;&#x02009;85.2<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">284.8&#x02009;&#x000b1;&#x02009;91.3<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Carbohydrate (g)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.286<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.049<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.386<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">345.2&#x02009;&#x000b1;&#x02009;116.2<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">295.8&#x02009;&#x000b1;&#x02009;45.3<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">308.1&#x02009;&#x000b1;&#x02009;66.1<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">11.3&#x02009;&#x000b1;&#x02009;3.3<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">12.8&#x02009;&#x000b1;&#x02009;4.1<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">11.2&#x02009;&#x000b1;&#x02009;4.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Salt (g)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.823<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.723<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.426<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">11.6&#x02009;&#x000b1;&#x02009;2.3<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">12.2&#x02009;&#x000b1;&#x02009;5.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">12.5&#x02009;&#x000b1;&#x02009;5.3<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">16.7&#x02009;&#x000b1;&#x02009;6.4<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">18.2&#x02009;&#x000b1;&#x02009;9.0<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">15.3&#x02009;&#x000b1;&#x02009;5.2<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Total dietary fiber (g)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.912<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.661<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.047<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">After 3&#x000a0;months<hr/></td><td align="center" valign="bottom">17.1&#x02009;&#x000b1;&#x02009;7.7<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">20.8&#x02009;&#x000b1;&#x02009;14.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">30.4&#x02009;&#x000b1;&#x02009;20.9<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">Baseline<hr/></td><td align="center" valign="bottom">355.1&#x02009;&#x000b1;&#x02009;156.1<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">298.4&#x02009;&#x000b1;&#x02009;203.5<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">292.4&#x02009;&#x000b1;&#x02009;146.6<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td></tr><tr><td align="center" valign="bottom">Total vegetables (g)<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.210<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.232<hr/></td><td align="center" valign="bottom">&#x000a0;<hr/></td><td align="center" valign="bottom">0.035<hr/></td></tr><tr><td align="center">&#x000a0;</td><td align="center">After 3&#x000a0;months</td><td align="center">273.8&#x02009;&#x000b1;&#x02009;152.2</td><td align="center">&#x000a0;</td><td align="center">211.0&#x02009;&#x000b1;&#x02009;110.0</td><td align="center">&#x000a0;</td><td align="center">411.1&#x02009;&#x000b1;&#x02009;155.9</td><td align="center">&#x000a0;</td></tr></tbody></table><table-wrap-foot><p>Data shows mean&#x02009;&#x000b1;&#x02009;S.D.</p><p><italic>p</italic> stands for the difference between the baseline parameters and the parameters after 3&#x000a0;months analyzed by the paired t-test.</p><p>Difference was considered significant at <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05.</p></table-wrap-foot></table-wrap></sec></sec><sec sec-type="discussion"><title>Discussion</title><p>Specific medical examinations and health guidance to prevent and/or improve metabolic syndrome have been implemented by insurers in Japan since 2008 to stem the increase in lifestyle-related diseases. However, the objectives of reducing health care costs, reducing abdominal obesity, and preventing metabolic syndrome have not yet been realized. The Healthy Japan 21 advocated by the Japanese Ministry of Health, Labour and Welfare (2000) recommends that adults ingest&#x02009;&#x02265;&#x02009;350&#x000a0;g of vegetables per day
[<xref ref-type="bibr" rid="B6">6</xref>]. Therefore, changes in food consumption patterns and environment must be incorporated into primary countermeasures against lifestyle-related diseases. Thus, we provided a Japanese-style healthy lunch menu daily for 3&#x000a0;months at a workplace cafeteria to examine the ability of consumption of this style of meal to prevent and/or improve metabolic syndrome.</p><p>The intervention group displayed reduced blood pressure and serum lipid markers after 3&#x000a0;months compared with the baseline. These improvements were observed particularly in cases where the intake frequency of the Japanese-style healthy lunch was high. Furthermore, plasma active ghrelin and desacyl ghrelin levels, which are related to appetite, increased compared with the baseline. These results mainly seem attributable to increased vegetable intake. In contrast with the intervention group, the control group showed unchanged biochemical markers and anthropometric data throughout the time frame of the study. Hung et al. reported that high fruit and vegetable intake helps to modestly reduce the risk of major chronic disease, and their findings support the recommendation of consuming at least five daily servings of fruits and vegetables
[<xref ref-type="bibr" rid="B16">16</xref>]. Increasing fruit and vegetable intake appears to confer a benefit primarily of a lower risk of CVD but not of cancer. The effect of the present intervention on cancer prevention is uncertain.</p><p>However, an increase in dietary fiber and vitamins could partly explain the lower blood pressure and decreased serum lipid markers observed in the intervention group. Fiber is a dietary factor that has received substantial attention
[<xref ref-type="bibr" rid="B17">17</xref>,<xref ref-type="bibr" rid="B18">18</xref>]. Burton-Freeman reported that dietary fiber functions as an energy intake regulator
[<xref ref-type="bibr" rid="B19">19</xref>]. Furthermore, the contents of the provided healthy lunches support the claim that the intervention group had an increase in total and soluble dietary fiber intake after compared with before the intervention. Liu et al. suggested that higher intake of fruits and vegetables can protect against CVD, and their findings support current dietary guidelines that promote increased fruit and vegetable intake
[<xref ref-type="bibr" rid="B20">20</xref>]. They also reported that higher intake of dark yellow and green leafy vegetables can help to prevent type 2 diabetes among overweight women
[<xref ref-type="bibr" rid="B20">20</xref>].</p><p>In addition, we surmised that a high-fiber diet increases the amount of mastication. Yamazaki et al. reported that higher masticatory performance and eating slowly helps prevent diabetes
[<xref ref-type="bibr" rid="B21">21</xref>]. Their results imply that higher mastication can decrease blood glucose and HbA<sub>1C</sub> levels. However, the present study did not find any changes in related blood parameters. We believe that blood parameters can be improved by lengthening the period of intervention and increasing the frequency with which individuals choose the foods offered on healthy menus.</p><p>In the intervention group, plasma active ghrelin and desacyl ghrelin levels significantly increased after 3&#x000a0;months compared with the baseline.</p><p>Ghrelin is an orexigenic hormone predominantly secreted by the stomach and stimulates appetite and food intake after i.v. administration
[<xref ref-type="bibr" rid="B22">22</xref>]. The postprandial ghrelin response depends on the nutrient composition of ingested meals, and several studies support the notion that elevated postprandial and later interdigestive ghrelin levels could contribute to recurrent hunger pangs and appetite
[<xref ref-type="bibr" rid="B23">23</xref>]. Ghrelin is a somatotropic and orexigenic hormone that functions as an important energy metabolism regulator
[<xref ref-type="bibr" rid="B22">22</xref>] and a physiological regulator of insulinemia and glycemia
[<xref ref-type="bibr" rid="B23">23</xref>]. Some studies have shown that circulating plasma ghrelin levels are lower in obese children and adults than in age-matched lean control individuals
[<xref ref-type="bibr" rid="B24">24</xref>,<xref ref-type="bibr" rid="B25">25</xref>]. Plasma ghrelin levels increase in individuals with a negative energy balance such as those on a low-energy diet or anti-obesity medication, or in those who exercise regularly
[<xref ref-type="bibr" rid="B26">26</xref>,<xref ref-type="bibr" rid="B27">27</xref>]. Furthermore, plasma ghrelin might play a role in energy balance
[<xref ref-type="bibr" rid="B27">27</xref>].</p><p>Horigome notably reported significant associations among hemostatic parameters, adipokines, and metabolic syndrome components among Japanese preschool children
[<xref ref-type="bibr" rid="B28">28</xref>]. Children with BMI of &#x02265;90%ile had significantly higher SBP and heart rates and higher blood levels of insulin and leptin
[<xref ref-type="bibr" rid="B28">28</xref>]. They also showed higher insulin resistance by the homeostasis model assessment and lower desacyl ghrelin levels than children with BMI of &#x0003c;90% ile
[<xref ref-type="bibr" rid="B28">28</xref>].</p><p>P&#x000f6;ykk&#x000f6; and Fagerberg described that ghrelin concentrations were negatively associated with fasting insulin and systolic and diastolic blood pressure in the multivariate models
[<xref ref-type="bibr" rid="B29">29</xref>,<xref ref-type="bibr" rid="B30">30</xref>]. SBP/DBP in the present study was significantly reduced after 3&#x000a0;months compared with the baseline.</p><p>Furthermore, serum leptin levels after 3&#x000a0;months were significantly reduced compared with the baseline in the intervention group. Particularly in the Japanese-style healthy lunch menu intake frequency&#x02009;&#x02265;&#x02009;50%ile group, BFP after 3&#x000a0;months significantly decreased compared with the baseline. Leptin, which is produced by adipose tissue, reduces food intake while increasing energy expenditure and positively correlates with fat mass
[<xref ref-type="bibr" rid="B31">31</xref>,<xref ref-type="bibr" rid="B32">32</xref>]. Elevated leptin levels are independently correlated with increased CVD risk
[<xref ref-type="bibr" rid="B33">33</xref>,<xref ref-type="bibr" rid="B34">34</xref>]. Reduced leptin levels while fasting during weight loss can be attributed to decreased leptin resistance
[<xref ref-type="bibr" rid="B35">35</xref>]. The relatively short duration of the intervention could explain the finding that BFP and serum leptin levels decreased in the present study. In the control group, no statistically significant differences in active ghrelin, desacyl ghrelin, and leptin concentrations between baseline and after 3&#x000a0;months were observed. It is unknown clinically. We believe that inspection by long-term intervention in a randomized clinical trial is necessary in future to determine the effect of ghrelin and leptin concentrations.</p><p>We believe that these findings will contribute to epoch-making metabolic syndrome prevention and improvement. However, this study is limited by its structure as a small non-randomized controlled trial. Hence, we plan to implement an additional intervention study with an increased number of participants.</p></sec><sec sec-type="conclusions"><title>Conclusions</title><p>This non-randomized controlled trial of a Japanese-style healthy lunch consumed at a workplace cafeteria aimed to prevent and/or improve metabolic syndrome among middle-aged men. The result revealed that continuing intake of a Japanese-style healthy lunch decreased blood pressure and serum lipids and increased plasma ghrelin levels. Our study results demonstrate that an intervention consisting of short-term consumption of a Japanese-style healthy lunch at a workplace cafeteria contributes to lipid metabolism regulation. These findings might lead to the design of a novel approach for improving the quality of food provision in out-of-home environments in Japan.</p></sec><sec><title>Abbreviations</title><p>UNESCO: United Nations Educational, Scientific and Cultural Organization; CVD: Cardiovascular disease; TG: Triacylglycerol; HDL-Chol: High-density lipoprotein; Healthy Japan 21: The National Health Promotion Campaigns for the 21st Century; T-Chol: Total cholesterol; BMI: Body mass index; HbA<sub>1C</sub>: Hemoglobin A<sub>1C</sub>; SBP: Systolic blood pressure; DBP: Diastolic blood pressure; BFP: Body fat percentage; LDL-Chol: Low-density lipoprotein; EDTA: Ethylenediaminetetraacetate; ELISA: enzyme-linked immunosorbent assay.</p></sec><sec><title>Competing interests</title><p>The authors of the manuscript declare no conflicts of interest.</p></sec><sec><title>Authors&#x02019; contributions</title><p>HI, RS and TK managed the study. HI, RS and IA conducted blood analysis and dietary assessment. HI, RS and TK undertook statistical analysis. HI and TK drafted the manuscript. All authors read and approved the final manuscript.</p></sec><sec><title>Authors&#x02019; information</title><p>Laboratory of Nutrition Education, Department of Food and Nutritional Sciences and Environmental Health Sciences, Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka, Shizuoka 422&#x02013;8526, Japan.</p><p>Hiroko Inoue is a registered dietitian, Ph.D., Ryosuke Sasaki is a registered dietitian, Izumi Aiso is a pharmaceutical chemist and Toshiko Kuwano is a registered dietitian, Ph.D., Department of Food and Nutritional Sciences and Environmental Health Sciences, Graduate School of Integrated Pharmaceutical and Nutritional Sciences, University of Shizuoka.</p></sec></body><back><sec><title>Acknowledgments</title><p>We are grateful to the city hall workers for participation in the study. This study was supported by the University of Shizuoka.</p></sec><ref-list><ref id="B1"><mixed-citation publication-type="journal"><name><surname>Yoshiike</surname><given-names>N</given-names></name><name><surname>Hayashi</surname><given-names>F</given-names></name><name><surname>Takemi</surname><given-names>Y</given-names></name><name><surname>Mizoguchi</surname><given-names>K</given-names></name><name><surname>Seino</surname><given-names>F</given-names></name><article-title>A new food guide in Japan; The Japanese food guide spinning top</article-title><source>Nutr Rev</source><year>2007</year><volume>65</volume><fpage>149</fpage><lpage>154</lpage><pub-id pub-id-type="doi">10.1301/nr.2007.apr.149-154</pub-id><pub-id pub-id-type="pmid">17503709</pub-id></mixed-citation></ref><ref id="B2"><mixed-citation publication-type="journal"><name><surname>Mottillo</surname><given-names>S</given-names></name><name><surname>Filion</surname><given-names>KB</given-names></name><name><surname>Genest</surname><given-names>J</given-names></name><name><surname>Joseph</surname><given-names>L</given-names></name><name><surname>Pilote</surname><given-names>L</given-names></name><name><surname>Poirier</surname><given-names>P</given-names></name><name><surname>Rinfret</surname><given-names>S</given-names></name><name><surname>Schiffrin</surname><given-names>EL</given-names></name><name><surname>Eisenberg</surname><given-names>MJ</given-names></name><article-title>The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis</article-title><source>J Am Coll Cardiol</source><year>2010</year><volume>56</volume><fpage>1113</fpage><lpage>1132</lpage><pub-id pub-id-type="doi">10.1016/j.jacc.2010.05.034</pub-id><pub-id pub-id-type="pmid">20863953</pub-id></mixed-citation></ref><ref id="B3"><mixed-citation publication-type="journal"><name><surname>Takeuchi</surname><given-names>H</given-names></name><name><surname>Saitoh</surname><given-names>S</given-names></name><name><surname>Takagi</surname><given-names>S</given-names></name><name><surname>Ohnishi</surname><given-names>H</given-names></name><name><surname>Ohhata</surname><given-names>J</given-names></name><name><surname>Isobe</surname><given-names>T</given-names></name><name><surname>Shimamoto</surname><given-names>K</given-names></name><article-title>Metabolic syndrome and cardiac disease in Japanese men: applicability of the concept of metabolic syndrome defined by the National Cholesterol Education Program-Adult Treatment Panel III to Japanese men-the Tanno and Sobetsu Study</article-title><source>Hypertens Res</source><year>2005</year><volume>28</volume><fpage>203</fpage><lpage>208</lpage><pub-id pub-id-type="doi">10.1291/hypres.28.203</pub-id><pub-id pub-id-type="pmid">16097362</pub-id></mixed-citation></ref><ref id="B4"><mixed-citation publication-type="journal"><name><surname>Moller</surname><given-names>DE</given-names></name><name><surname>Kaufman</surname><given-names>KD</given-names></name><article-title>Metabolic syndrome: a clinical and molecular perspective</article-title><source>Annu Rev Med</source><year>2005</year><volume>56</volume><fpage>45</fpage><lpage>62</lpage><pub-id pub-id-type="doi">10.1146/annurev.med.56.082103.104751</pub-id><pub-id pub-id-type="pmid">15660501</pub-id></mixed-citation></ref><ref id="B5"><mixed-citation publication-type="journal"><name><surname>Devaraj</surname><given-names>S</given-names></name><name><surname>Rosenson</surname><given-names>RS</given-names></name><name><surname>Jialal</surname><given-names>I</given-names></name><article-title>Metabolic syndrome: an appraisal of the pro-inflammatory and procoagulant status</article-title><source>Endocrinol Metab Clin North Am</source><year>2004</year><volume>33</volume><fpage>431</fpage><lpage>453</lpage><pub-id pub-id-type="doi">10.1016/j.ecl.2004.03.008</pub-id><pub-id pub-id-type="pmid">15158528</pub-id></mixed-citation></ref><ref id="B6"><mixed-citation publication-type="other"><collab>The Ministry of Health, Labor and Welfare</collab><source>Health Japan 21</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.dietitian.or.jp/english/images/health_japan21.pdf">http://www.dietitian.or.jp/english/images/health_japan21.pdf</ext-link></comment></mixed-citation></ref><ref id="B7"><mixed-citation publication-type="other"><collab>The Ministry of Health, Labor and Welfare</collab><source>The National Health and Nutrition Survey Japan</source><comment><ext-link ext-link-type="uri" xlink:href="http://www.mhlw.go.jp/english/wp/wp-hw5/dl/23010220e.pdf">http://www.mhlw.go.jp/english/wp/wp-hw5/dl/23010220e.pdf</ext-link></comment></mixed-citation></ref><ref id="B8"><mixed-citation publication-type="journal"><name><surname>Mori</surname><given-names>M</given-names></name><name><surname>Hamada</surname><given-names>A</given-names></name><name><surname>Mori</surname><given-names>H</given-names></name><name><surname>Yamori</surname><given-names>Y</given-names></name><name><surname>Tsuda</surname><given-names>K</given-names></name><article-title>Effects of cooking using multi-ply cookware on absorption of potassium and vitamins: a randomized double-blind placebo control study</article-title><source>Int J Food Sci Nutr</source><year>2012</year><volume>63</volume><fpage>530</fpage><lpage>536</lpage><pub-id pub-id-type="doi">10.3109/09637486.2011.642342</pub-id><pub-id pub-id-type="pmid">22229802</pub-id></mixed-citation></ref><ref id="B9"><mixed-citation publication-type="journal"><name><surname>Jones</surname><given-names>JL</given-names></name><name><surname>Comperatore</surname><given-names>M</given-names></name><name><surname>Barona</surname><given-names>J</given-names></name><name><surname>Calle</surname><given-names>MC</given-names></name><name><surname>Andersen</surname><given-names>C</given-names></name><name><surname>McIntosh</surname><given-names>M</given-names></name><name><surname>Najm</surname><given-names>W</given-names></name><name><surname>Lerman</surname><given-names>RH</given-names></name><name><surname>Fernandez</surname><given-names>ML</given-names></name><article-title>A Mediterranean-style, low-glycemic-load diet decreases atherogenic lipoproteins and reduces lipoprotein (a) and oxidized low-density lipoprotein in women with metabolic syndrome</article-title><source>Metabolism</source><year>2012</year><volume>61</volume><fpage>366</fpage><lpage>372</lpage><pub-id pub-id-type="doi">10.1016/j.metabol.2011.07.013</pub-id><pub-id pub-id-type="pmid">21944261</pub-id></mixed-citation></ref><ref id="B10"><mixed-citation publication-type="journal"><name><surname>Barona</surname><given-names>J</given-names></name><name><surname>Jones</surname><given-names>JJ</given-names></name><name><surname>Kopec</surname><given-names>RE</given-names></name><name><surname>Comperatore</surname><given-names>M</given-names></name><name><surname>Andersen</surname><given-names>C</given-names></name><name><surname>Schwartz</surname><given-names>SJ</given-names></name><name><surname>Lerman</surname><given-names>RH</given-names></name><name><surname>Fernandez</surname><given-names>ML</given-names></name><article-title>A Mediterranean-style low-glycemic-load diet increases plasma carotenoids and decreases LDL oxidation in women with metabolic syndrome</article-title><source>J Nutr Biochem</source><year>2012</year><volume>23</volume><fpage>609</fpage><lpage>615</lpage><pub-id pub-id-type="doi">10.1016/j.jnutbio.2011.02.016</pub-id><pub-id pub-id-type="pmid">21775117</pub-id></mixed-citation></ref><ref id="B11"><mixed-citation publication-type="journal"><name><surname>Leighton</surname><given-names>F</given-names></name><name><surname>Polic</surname><given-names>G</given-names></name><name><surname>Strobel</surname><given-names>P</given-names></name><name><surname>P&#x000e9;rez</surname><given-names>D</given-names></name><name><surname>Mart&#x000ed;nez</surname><given-names>C</given-names></name><name><surname>V&#x000e1;squez</surname><given-names>L</given-names></name><name><surname>Castillo</surname><given-names>O</given-names></name><name><surname>Villarroel</surname><given-names>L</given-names></name><name><surname>Echeverr&#x000ed;a</surname><given-names>G</given-names></name><name><surname>Urquiaga</surname><given-names>I</given-names></name><name><surname>Mezzano</surname><given-names>D</given-names></name><name><surname>Rozowski</surname><given-names>J</given-names></name><article-title>Health impact of Mediterranean diets in food at work</article-title><source>Public Health Nutr</source><year>2009</year><volume>12</volume><fpage>1635</fpage><lpage>1643</lpage><pub-id pub-id-type="doi">10.1017/S1368980009990486</pub-id><pub-id pub-id-type="pmid">19689833</pub-id></mixed-citation></ref><ref id="B12"><mixed-citation publication-type="journal"><name><surname>LeCheminant</surname><given-names>JD</given-names></name><name><surname>Smith</surname><given-names>BK</given-names></name><name><surname>Westman</surname><given-names>EC</given-names></name><name><surname>Vernon</surname><given-names>MC</given-names></name><name><surname>Donnelly</surname><given-names>JE</given-names></name><article-title>Comparison of a reduced carbohydrate and reduced fat diet for LDL, HDL, and VLDL subclasses during 9-months of weight maintenance subsequent to weight loss</article-title><source>Lipids Health Dis</source><year>2010</year><volume>9</volume><fpage>54</fpage><pub-id pub-id-type="doi">10.1186/1476-511X-9-54</pub-id><pub-id pub-id-type="pmid">20515484</pub-id></mixed-citation></ref><ref id="B13"><mixed-citation publication-type="journal"><name><surname>Shin</surname><given-names>A</given-names></name><name><surname>Lim</surname><given-names>SY</given-names></name><name><surname>Sung</surname><given-names>J</given-names></name><name><surname>Shin</surname><given-names>HR</given-names></name><name><surname>Kim</surname><given-names>J</given-names></name><article-title>Dietary intake, eating habits, and metabolic syndrome in Korean men</article-title><source>J Am Diet Assoc</source><year>2009</year><volume>109</volume><fpage>633</fpage><lpage>640</lpage><pub-id pub-id-type="doi">10.1016/j.jada.2008.12.015</pub-id><pub-id pub-id-type="pmid">19328258</pub-id></mixed-citation></ref><ref id="B14"><mixed-citation publication-type="journal"><name><surname>Panagiotakos</surname><given-names>DB</given-names></name><name><surname>Pitsavos</surname><given-names>C</given-names></name><name><surname>Skoumas</surname><given-names>Y</given-names></name><name><surname>Stefanadis</surname><given-names>C</given-names></name><article-title>The association between food patterns and the metabolic syndrome using principal components analysis: The ATTICA Study</article-title><source>J Am Diet Assoc</source><year>2007</year><volume>107</volume><fpage>979</fpage><lpage>987</lpage><pub-id pub-id-type="doi">10.1016/j.jada.2007.03.006</pub-id><pub-id pub-id-type="pmid">17524719</pub-id></mixed-citation></ref><ref id="B15"><mixed-citation publication-type="journal"><name><surname>Teramoto</surname><given-names>T</given-names></name><name><surname>Sasaki</surname><given-names>J</given-names></name><name><surname>Ueshima</surname><given-names>H</given-names></name><name><surname>Egusa</surname><given-names>G</given-names></name><name><surname>Kinoshita</surname><given-names>M</given-names></name><name><surname>Shimamoto</surname><given-names>K</given-names></name><name><surname>Daida</surname><given-names>H</given-names></name><name><surname>Biro</surname><given-names>S</given-names></name><name><surname>Hirobe</surname><given-names>K</given-names></name><name><surname>Funahashi</surname><given-names>T</given-names></name><name><surname>Yokote</surname><given-names>K</given-names></name><name><surname>Yokode</surname><given-names>M</given-names></name><article-title>Risk factors of atherosclerotic diseases. Executive summary of Japan Atherosclerosis Society (JAS) guideline for diagnosis and prevention of atherosclerosis cardiovascular diseases for Japanese</article-title><source>J Atheroscler Thromb</source><year>2007</year><volume>14</volume><fpage>45</fpage><lpage>50</lpage><pub-id pub-id-type="doi">10.5551/jat.14.45</pub-id><pub-id pub-id-type="pmid">17485887</pub-id></mixed-citation></ref><ref id="B16"><mixed-citation publication-type="journal"><name><surname>Hung</surname><given-names>HC</given-names></name><name><surname>Joshipura</surname><given-names>KJ</given-names></name><name><surname>Jiang</surname><given-names>R</given-names></name><name><surname>Hu</surname><given-names>FB</given-names></name><name><surname>Hunter</surname><given-names>D</given-names></name><name><surname>Smith-Warner</surname><given-names>SA</given-names></name><name><surname>Colditz</surname><given-names>GA</given-names></name><name><surname>Rosner</surname><given-names>B</given-names></name><name><surname>Spiegelman</surname><given-names>D</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><article-title>Fruit and vegetable intake and risk of major chronic disease</article-title><source>J Natl Cancer Inst</source><year>2004</year><volume>96</volume><fpage>1577</fpage><lpage>1584</lpage><pub-id pub-id-type="doi">10.1093/jnci/djh296</pub-id><pub-id pub-id-type="pmid">15523086</pub-id></mixed-citation></ref><ref id="B17"><mixed-citation publication-type="journal"><name><surname>Schulz</surname><given-names>M</given-names></name><name><surname>N&#x000f6;thlings</surname><given-names>U</given-names></name><name><surname>Hoffmann</surname><given-names>K</given-names></name><name><surname>Bergmann</surname><given-names>MM</given-names></name><name><surname>Boeing</surname><given-names>H</given-names></name><article-title>Identification of a food pattern characterized by high-fiber and low-fat food choices associated with low prospective weight change in the EPIC-Potsdam cohort</article-title><source>J Nutr</source><year>2005</year><volume>135</volume><fpage>1183</fpage><lpage>1189</lpage><pub-id pub-id-type="pmid">15867301</pub-id></mixed-citation></ref><ref id="B18"><mixed-citation publication-type="journal"><name><surname>Slavin</surname><given-names>JL</given-names></name><article-title>Dietary fiber and body weight</article-title><source>Nutrition</source><year>2005</year><volume>21</volume><fpage>411</fpage><lpage>418</lpage><pub-id pub-id-type="doi">10.1016/j.nut.2004.08.018</pub-id><pub-id pub-id-type="pmid">15797686</pub-id></mixed-citation></ref><ref id="B19"><mixed-citation publication-type="journal"><name><surname>Burton-Freeman</surname><given-names>B</given-names></name><article-title>Dietary fiber and energy regulation</article-title><source>J Nutr</source><year>2000</year><volume>130</volume><issue>2S Suppl</issue><fpage>272S</fpage><lpage>275S</lpage><pub-id pub-id-type="pmid">10721886</pub-id></mixed-citation></ref><ref id="B20"><mixed-citation publication-type="journal"><name><surname>Liu</surname><given-names>S</given-names></name><name><surname>Manson</surname><given-names>JE</given-names></name><name><surname>Lee</surname><given-names>IM</given-names></name><name><surname>Cole</surname><given-names>SR</given-names></name><name><surname>Hennekens</surname><given-names>CH</given-names></name><name><surname>Willett</surname><given-names>WC</given-names></name><name><surname>Buring</surname><given-names>JE</given-names></name><article-title>Fruit and vegetable intake and risk of cardiovascular disease: the Women's Health Study</article-title><source>Am J Clin Nutr</source><year>2000</year><volume>72</volume><fpage>922</fpage><lpage>928</lpage><pub-id pub-id-type="pmid">11010932</pub-id></mixed-citation></ref><ref id="B21"><mixed-citation publication-type="journal"><name><surname>Yamazaki</surname><given-names>T</given-names></name><name><surname>Yamori</surname><given-names>M</given-names></name><name><surname>Asai</surname><given-names>K</given-names></name><name><surname>Nakano-Araki</surname><given-names>I</given-names></name><name><surname>Yamaguchi</surname><given-names>A</given-names></name><name><surname>Takahashi</surname><given-names>K</given-names></name><name><surname>Sekine</surname><given-names>A</given-names></name><name><surname>Matsuda</surname><given-names>F</given-names></name><name><surname>Kosugi</surname><given-names>S</given-names></name><name><surname>Nakayama</surname><given-names>T</given-names></name><name><surname>Inagaki</surname><given-names>N</given-names></name><name><surname>Bessho</surname><given-names>K</given-names></name><collab>Nagahama Study Collaboration Group</collab><article-title>Mastication and risk for diabetes in a Japanese population: a cross-sectional study</article-title><source>PLoS One</source><year>2013</year><volume>8</volume><fpage>e64113</fpage><pub-id pub-id-type="doi">10.1371/journal.pone.0064113</pub-id><pub-id pub-id-type="pmid">23755114</pub-id></mixed-citation></ref><ref id="B22"><mixed-citation publication-type="journal"><name><surname>Kojima</surname><given-names>M</given-names></name><name><surname>Hosoda</surname><given-names>H</given-names></name><name><surname>Date</surname><given-names>Y</given-names></name><name><surname>Nakazato</surname><given-names>M</given-names></name><name><surname>Matsuo</surname><given-names>H</given-names></name><name><surname>Kangawa</surname><given-names>K</given-names></name><article-title>Ghrelin is a growth-hormone-releasing acylated peptide from stomach</article-title><source>Nature</source><year>1999</year><volume>402</volume><fpage>656</fpage><lpage>660</lpage><pub-id pub-id-type="doi">10.1038/45230</pub-id><pub-id pub-id-type="pmid">10604470</pub-id></mixed-citation></ref><ref id="B23"><mixed-citation publication-type="journal"><name><surname>Vendrell</surname><given-names>J</given-names></name><name><surname>Broch</surname><given-names>M</given-names></name><name><surname>Vilarrasa</surname><given-names>N</given-names></name><name><surname>Molina</surname><given-names>A</given-names></name><name><surname>G&#x000f3;mez</surname><given-names>JM</given-names></name><name><surname>Guti&#x000e9;rrez</surname><given-names>C</given-names></name><name><surname>Sim&#x000f3;n</surname><given-names>I</given-names></name><name><surname>Soler</surname><given-names>J</given-names></name><name><surname>Richart</surname><given-names>C</given-names></name><article-title>Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity</article-title><source>Obes Res</source><year>2004</year><volume>12</volume><fpage>962</fpage><lpage>971</lpage><pub-id pub-id-type="doi">10.1038/oby.2004.118</pub-id><pub-id pub-id-type="pmid">15229336</pub-id></mixed-citation></ref><ref id="B24"><mixed-citation publication-type="journal"><name><surname>Reinehr</surname><given-names>T</given-names></name><name><surname>de Sousa</surname><given-names>G</given-names></name><name><surname>Roth</surname><given-names>CL</given-names></name><article-title>Obestatin and ghrelin levels in obese children and adolescents before and after reduction of overweight</article-title><source>Clin Endocrinol (Oxf)</source><year>2008</year><volume>68</volume><fpage>304</fpage><lpage>310</lpage><pub-id pub-id-type="pmid">17854392</pub-id></mixed-citation></ref><ref id="B25"><mixed-citation publication-type="journal"><name><surname>Bacha</surname><given-names>F</given-names></name><name><surname>Arslanian</surname><given-names>SA</given-names></name><article-title>Ghrelin suppression in overweight children: a manifestation of insulin resistance?</article-title><source>J Clin Endocrinol Metab</source><year>2005</year><volume>90</volume><fpage>2725</fpage><lpage>2730</lpage><pub-id pub-id-type="doi">10.1210/jc.2004-1582</pub-id><pub-id pub-id-type="pmid">15728212</pub-id></mixed-citation></ref><ref id="B26"><mixed-citation publication-type="journal"><name><surname>Reinehr</surname><given-names>T</given-names></name><name><surname>Roth</surname><given-names>CL</given-names></name><name><surname>Alexy</surname><given-names>U</given-names></name><name><surname>Kersting</surname><given-names>M</given-names></name><name><surname>Kiess</surname><given-names>W</given-names></name><name><surname>Andler</surname><given-names>W</given-names></name><article-title>Ghrelin levels before and after reduction of overweight due to a low-fat high-carbohydrate diet in obese children and adolescents</article-title><source>Int J Obes (Lond)</source><year>2005</year><volume>29</volume><fpage>362</fpage><lpage>368</lpage><pub-id pub-id-type="doi">10.1038/sj.ijo.0802913</pub-id><pub-id pub-id-type="pmid">15768041</pub-id></mixed-citation></ref><ref id="B27"><mixed-citation publication-type="journal"><name><surname>Gil-Campos</surname><given-names>M</given-names></name><name><surname>Aguilera</surname><given-names>CM</given-names></name><name><surname>Ca&#x000f1;ete</surname><given-names>R</given-names></name><name><surname>Gil</surname><given-names>A</given-names></name><article-title>Ghrelin: a hormone regulating food intake and energy homeostasis</article-title><source>Br J Nutr</source><year>2006</year><volume>96</volume><fpage>201</fpage><lpage>226</lpage><pub-id pub-id-type="doi">10.1079/BJN20061787</pub-id><pub-id pub-id-type="pmid">16923214</pub-id></mixed-citation></ref><ref id="B28"><mixed-citation publication-type="journal"><name><surname>Horigome</surname><given-names>H</given-names></name><name><surname>Katayama</surname><given-names>Y</given-names></name><name><surname>Yoshinaga</surname><given-names>M</given-names></name><name><surname>Kato</surname><given-names>Y</given-names></name><name><surname>Takahashi</surname><given-names>H</given-names></name><name><surname>Sumazaki</surname><given-names>R</given-names></name><article-title>Significant associations among hemostatic parameters, adipokines, and components of the metabolic syndrome in Japanese preschool children</article-title><source>Clin Appl Thromb Hemost</source><year>2012</year><volume>18</volume><fpage>189</fpage><lpage>194</lpage><pub-id pub-id-type="doi">10.1177/1076029611418962</pub-id><pub-id pub-id-type="pmid">21949035</pub-id></mixed-citation></ref><ref id="B29"><mixed-citation publication-type="journal"><name><surname>P&#x000f6;ykk&#x000f6;</surname><given-names>SM</given-names></name><name><surname>Kellokoski</surname><given-names>E</given-names></name><name><surname>H&#x000f6;rkk&#x000f6;</surname><given-names>S</given-names></name><name><surname>Kauma</surname><given-names>H</given-names></name><name><surname>Kes&#x000e4;niemi</surname><given-names>YA</given-names></name><name><surname>Ukkola</surname><given-names>O</given-names></name><article-title>Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes</article-title><source>Diabetes</source><year>2003</year><volume>52</volume><fpage>2546</fpage><lpage>2553</lpage><pub-id pub-id-type="doi">10.2337/diabetes.52.10.2546</pub-id><pub-id pub-id-type="pmid">14514639</pub-id></mixed-citation></ref><ref id="B30"><mixed-citation publication-type="journal"><name><surname>Fagerberg</surname><given-names>B</given-names></name><name><surname>Hult&#x000e9;n</surname><given-names>LM</given-names></name><name><surname>Hulthe</surname><given-names>J</given-names></name><article-title>Plasma ghrelin, body fat, insulin resistance, and smoking in clinically healthy men: the atherosclerosis and insulin resistance study</article-title><source>Metabolism</source><year>2003</year><volume>52</volume><fpage>1460</fpage><lpage>1463</lpage><pub-id pub-id-type="doi">10.1016/S0026-0495(03)00274-9</pub-id><pub-id pub-id-type="pmid">14624407</pub-id></mixed-citation></ref><ref id="B31"><mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Y</given-names></name><name><surname>Proenca</surname><given-names>R</given-names></name><name><surname>Maffei</surname><given-names>M</given-names></name><name><surname>Barone</surname><given-names>M</given-names></name><name><surname>Leopold</surname><given-names>L</given-names></name><name><surname>Friedman</surname><given-names>JM</given-names></name><article-title>Positional cloning of the mouse obese gene and its human homologue</article-title><source>Nature</source><year>1994</year><volume>372</volume><fpage>425</fpage><lpage>432</lpage><pub-id pub-id-type="doi">10.1038/372425a0</pub-id><pub-id pub-id-type="pmid">7984236</pub-id></mixed-citation></ref><ref id="B32"><mixed-citation publication-type="journal"><name><surname>Considine</surname><given-names>RV</given-names></name><name><surname>Sinha</surname><given-names>MK</given-names></name><name><surname>Heiman</surname><given-names>ML</given-names></name><name><surname>Kriauciunas</surname><given-names>A</given-names></name><name><surname>Stephens</surname><given-names>TW</given-names></name><name><surname>Nyce</surname><given-names>MR</given-names></name><name><surname>Ohannesian</surname><given-names>JP</given-names></name><name><surname>Marco</surname><given-names>CC</given-names></name><name><surname>McKee</surname><given-names>LJ</given-names></name><name><surname>Bauer</surname><given-names>TL</given-names></name><name><surname>Caro</surname><given-names>JF</given-names></name><article-title>Serum immunoreactive-leptin concentrations in normal-weight and obese humans</article-title><source>N Engl J Med</source><year>1996</year><volume>334</volume><fpage>292</fpage><lpage>295</lpage><pub-id pub-id-type="doi">10.1056/NEJM199602013340503</pub-id><pub-id pub-id-type="pmid">8532024</pub-id></mixed-citation></ref><ref id="B33"><mixed-citation publication-type="journal"><name><surname>Wallace</surname><given-names>AM</given-names></name><name><surname>McMahon</surname><given-names>AD</given-names></name><name><surname>Packard</surname><given-names>CJ</given-names></name><name><surname>Kelly</surname><given-names>A</given-names></name><name><surname>Shepherd</surname><given-names>J</given-names></name><name><surname>Gaw</surname><given-names>A</given-names></name><name><surname>Sattar</surname><given-names>N</given-names></name><article-title>Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS)</article-title><source>Circulation</source><year>2001</year><volume>104</volume><fpage>3052</fpage><lpage>3056</lpage><pub-id pub-id-type="doi">10.1161/hc5001.101061</pub-id><pub-id pub-id-type="pmid">11748099</pub-id></mixed-citation></ref><ref id="B34"><mixed-citation publication-type="journal"><name><surname>S&#x000f6;derberg</surname><given-names>S</given-names></name><name><surname>Ahr&#x000e9;n</surname><given-names>B</given-names></name><name><surname>Stegmayr</surname><given-names>B</given-names></name><name><surname>Johnson</surname><given-names>O</given-names></name><name><surname>Wiklund</surname><given-names>PG</given-names></name><name><surname>Weinehall</surname><given-names>L</given-names></name><name><surname>Hallmans</surname><given-names>G</given-names></name><name><surname>Olsson</surname><given-names>T</given-names></name><article-title>Leptin is a risk marker for first-ever hemorrhagic stroke in a population-based cohort</article-title><source>Stroke</source><year>1999</year><volume>30</volume><fpage>328</fpage><lpage>337</lpage><pub-id pub-id-type="doi">10.1161/01.STR.30.2.328</pub-id><pub-id pub-id-type="pmid">9933268</pub-id></mixed-citation></ref><ref id="B35"><mixed-citation publication-type="journal"><name><surname>Enriori</surname><given-names>PJ</given-names></name><name><surname>Evans</surname><given-names>AE</given-names></name><name><surname>Sinnayah</surname><given-names>P</given-names></name><name><surname>Cowley</surname><given-names>MA</given-names></name><article-title>Leptin resistance and obesity</article-title><source>Obesity (Silver Spring)</source><year>2006</year><volume>14</volume><issue>Suppl 5</issue><fpage>254S</fpage><lpage>258S</lpage><pub-id pub-id-type="pmid">17021377</pub-id></mixed-citation></ref></ref-list></back></article>